INCLISIRAN- A breakthrough revolution in the treatment of hypercholesterolemia
DOI:
https://doi.org/10.47391/JPMA.6629Abstract
We are submitting a Letter to the Editor. It doesn't require abstract.
Downloads
Published
2022-12-15
Issue
Section
Letter to the Editor